Early Evaluation of Patient Risk for Substantial Weight Gain During Olanzapine Treatment for Schizophrenia, Schizophreniform, or Schizoaffective Disorder
BMC Psychiatry - United Kingdom
doi 10.1186/1471-244x-8-78
Full Text
Open PDFAbstract
Available in full text
Date
September 15, 2008
Authors
Publisher
Springer Science and Business Media LLC